Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott today officially opened its new diabetes technology manufacturing facility in Kilkenny, Ireland. The site will employ ...

Abbott (NYSE: ABT) today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Combine continuous glucose monitoring data from the FreeStyle Libre 2 system, from wherever you are*, along with expert advice from your health coach help you make informed decisions to keep enjoying ...

the integration of continuous glucose monitoring (CGM) data directly into electronic health record (EHR) clinical workflows.

The site is a global manufacturing centre of excellence for Abbott’s diabetes care business and will employ more than 800 ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.